Women's Health Research
From the FDA Office of Women's Health
OWH promotes initiatives and conducts research that facilitate FDA regulatory decision-making and advance the understanding of sex differences and health conditions unique to women.
IN THIS SECTION
![Woman researcher](https://public4.pagefreezer.com:443/content/FDA/31-12-2023T10:22/https://www.fda.gov/files/styles/medium_3/public/Woman%20Researcher.jpg?itok=YwMkASbI)
About OWH Research
OWH scientific programs support research, workshops, and initiatives that advance understanding of women’s health issues.
![Two Female Researchers](https://public4.pagefreezer.com:443/content/FDA/31-12-2023T10:22/https://www.fda.gov/files/styles/medium_3/public/iStock-1207087144.jpg?itok=U3IroqGi)
OWH-funded research
Learn more about research funded by OWH, including how to apply for extramural research funding, and view a searchable list of projects.
![Female doctor and health care providers](https://public4.pagefreezer.com:443/content/FDA/31-12-2023T10:22/https://www.fda.gov/files/styles/medium_3/public/iStock-813533668%20copy_0.jpg?itok=TfrcyLxI)
Peer-reviewed scientific publications
OWH staff and OWH-funded researchers are working to advance the science of sex differences. View peer-reviewed publications.
RELATED INFORMATION
![Image of smiling black pregnant woman](https://public4.pagefreezer.com:443/content/FDA/31-12-2023T10:22/https://www.fda.gov/files/styles/medium_3/public/AA%20pregnant%20woman%20in%20orange%20dress%20smiling_web%20resize_CROP.jpg?itok=lak3l54w)
Pregnancy exposure registries
Information collected can help health care providers and those who are pregnant learn more about the safety of medicines and vaccines used during pregnancy.
![Young minority women](https://public4.pagefreezer.com:443/content/FDA/31-12-2023T10:22/https://www.fda.gov/files/styles/medium_3/public/YoungWomen_Minority_Office_copy.jpg?itok=03lGg4zT)
Women's health education and training
Find continuing education opportunities, upcoming events, and subscribe to receive the latest information about future opportunities from OWH.
![FDA Office of Women's Health Public Workshop Menopause: Potential Impact on Clinical Pharmacology and Opportunities for Future Research](https://public4.pagefreezer.com:443/content/FDA/31-12-2023T10:22/https://www.fda.gov/files/styles/medium_3/public/FDA_OWH_Menopause_EventMaterials_WebGraphic_1600x900_v2.jpg?itok=RCQMf6uu)
Menopause: Potential Impact on Clinical Pharmacology
At this OWH workshop, speakers discussed the current understanding of the impact of menopause on the pharmacokinetics and pharmacodynamics, and exposure-response relationships of FDA-regulated drugs and biologics used by menopausal women for non-menopause-related indications.
Paragraph Header
Contact the FDA Office of Women's Health
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993